850 
Effect of Different Enfuvirtide-resistance Mutations on Variability of the Rev Responsive Element and the rev Gene in Patients on Enfuvirtide Treatment
Eva Poveda*, M Gonzalez, V Briz, J Gonzalez-Lahoz, and V Soriano
Hosp Carlos III, Madrid, Spain
Background: The
rev response element (RRE) contains the gp41 region (amino acids 36 to 45) in
which enfuvirtide (T-20) -resistance mutations are selected. Therefore, the RRE
structure and RRE-rev interactions, which are critical in the HIV replication
cycle, might be influenced by T-20-resistance changes. The genetic variability
of RRE and rev sequences was examined in patients harbouring different patterns
of T-20-resistance mutations.
Methods: We
identified 10 patients who began T-20 salvage therapy and subsequently showed
virological failure. Clonal analysis of gp41 was performed on a total of 23
plasma samples collected on longitudinal follow-up (range, 8 to 264 weeks on
T-20). Sequences generated were analyzed for both the RRE and the gp41 open
reading frame. RRE secondary structures were predicted using the RNA-fold
program. The rev protein (exons 1 and 2) was sequenced at baseline and upon
selection of specific T-20-resistance mutations.
Results: A
total of 421 clones were generated from 23 samples harboring distinct T-20-mutation
patterns: 1 G36V, 1 G36V+L44V, 3 G36D+L44V, 1 G36D+L40V, 1 V38E, 1
V38A/V+N43D/N, 1 Q39H+N43D, 1 Q39R+N43D, 1 Q40H, 2 N42T+N43K, 2 N42K+N43D, 2
N43D+Q40H, 4 N43D, 1 N43D+L44M, and 1 L45W. Selection
of double mutations was observed in 6 patients during weeks 16 and 212 of T-20
therapy. Mutations at codons 36, 38, and 43 were always present in separate
clones. Conversely, changes Q39H/R, N42T/K, or L44M/V always appeared together
with mutations at positions 36, 38, or 43. The RRE motif 5’-CACTATGGG-3’, known
as the “high affinity rev binding site,” was highly conserved in all clones.
The predicted RRE secondary structure showed a minimal effect of T-20-resistance
mutations at positions 36, 39, 40, 42, 43, or 44 on the critical region for
RRE-rev interactions. However, mutations V38A and V38E significantly altered
the secondary structure of the “high affinity rev binding site.” The rev
protein was examined in 24 samples before and upon selection of T-20-resistance
changes. No evolution of amino acid substitutions was observed, even in
patients harboring changes at codon 38 in gp41.
Conclusions:
The “high affinity rev binding site” of RRE is highly conserved in T-20-resistant
clones. V38A and V38E mutations are predicted to alter the critical region for
RRE-rev interactions. T-20-resistance mutations do not seem to have any effect
on the rev protein.
|